Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 114 results:
Author [ Title] Type Year Filters: Author is Doumas, Michael [Clear All Filters]
Primary aldosteronism in patients with adrenal incidentaloma: Is screening appropriate for everyone?.
J Clin Hypertens (Greenwich). 20(5), 942-948.
(2018). Prognostic value of arterial stiffness measurements in cardiovascular disease, diabetes, and its complications: The potential role of sodium-glucose co-transporter-2 inhibitors..
J Clin Hypertens (Greenwich).
(2020). Psoriasis and Cardiovascular Disease: Two Sides of the Same Coin?.
Angiology. 69(1), 5-9.
(2018). Reduction of Vascular Inflammation, LDL-C, or Both for the Protection from Cardiovascular Events?.
Open Cardiovasc Med J. 12, 29-40.
(2018). Renal denervation and Symplicity HTN-3: "Dubium sapientiae initium" (doubt is the beginning of wisdom)..
Circ Res. 115(2), 211-4.
(2014). Renal Denervation Therapy for Drug-Resistant Hypertension: Does It Still Work?.
Curr Treat Options Cardiovasc Med. 19(5), 39.
(2017). Renal nerve ablation for resistant hypertension: how did we get here, present status, and future directions..
Circulation. 129(13), 1440-51.
(2014). Renal nerve ablation for resistant hypertension: the dust has not yet settled..
J Clin Hypertens (Greenwich). 16(6), 399-400.
(2014). Renal resistive index for renovascular hypertension: In the quest of the Holy Grail..
J Clin Hypertens (Greenwich). 20(3), 589-591.
(2018). Renal sympathetic denervation and systemic hypertension..
Am J Cardiol. 105(4), 570-6.
(2010). Renal sympathetic denervation: Ashes to ashes or rebirth from the ashes?.
J Clin Hypertens (Greenwich). 20(4), 634-636.
(2018). Renal Sympathetic Denervation: Hibernation or Resurrection?.
Cardiology. 135(2), 87-97.
(2016). Renal sympathetic denervation in hypertension..
Curr Opin Nephrol Hypertens. 20(6), 647-53.
(2011). Renal sympathetic denervation: renal function concerns..
Hypertension. 58(4), e19; author reply e20.
(2011). Renal sympathetic denervation: the jury is still out..
Lancet. 376(9756), 1878-80.
(2010). Resolution of non-alcoholic steatohepatitis by rosuvastatin monotherapy in patients with metabolic syndrome..
World J Gastroenterol. 21(25), 7860-8.
(2015).
(2019). Sacubitril/valsartan instead of renin-angiotensin system inhibition alone: A step forward in resistant hypertension..
J Clin Hypertens (Greenwich). 20(1), 65-68.
(2018). Screening for Primary Aldosteronism: Whom and How?.
J Clin Hypertens (Greenwich). 17(7), 547-8.
(2015). SGLT-2 Inhibitors and Cardiovascular Risk in Diabetes Mellitus: A Comprehensive and Critical Review of the Literature..
Curr Pharm Des. 23(10), 1510-1521.
(2017). Should ambulatory blood pressure monitoring be mandatory for future studies in resistant hypertension: a perspective..
J Hypertens. 30(5), 874-6.
(2012). Sodium-glucose Cotransporter 2 Inhibitors: Nephroprotective Impact on Diabetic Kidney Disease..
Cardiovasc Hematol Disord Drug Targets. 18(2), 120-126.
(2018). Sodium-glucose Co-transporters 2 Inhibitors: The Miraculous Route from Hypoglycemic to Cardiovascular Drugs..
Cardiovasc Hematol Disord Drug Targets. 18(2), 83-85.
(2018). Statin and exercise prescription - Authors' reply..
Lancet. 381(9878), 1622-3.
(2013). Statin therapy, fitness, and mortality risk in middle-aged hypertensive male veterans..
Am J Hypertens. 27(3), 422-30.
(2014).